The store will not work correctly when cookies are disabled.
7-((6-(4-fluorophenyl)pyridin-3-ylsulfonyl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine
ID: ALA1078268
PubChem CID: 46882753
Max Phase: Preclinical
Molecular Formula: C22H21FN2O2S
Molecular Weight: 396.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=S(=O)(Cc1ccc2c(c1)CCNCC2)c1ccc(-c2ccc(F)cc2)nc1
Standard InChI: InChI=1S/C22H21FN2O2S/c23-20-5-3-18(4-6-20)22-8-7-21(14-25-22)28(26,27)15-16-1-2-17-9-11-24-12-10-19(17)13-16/h1-8,13-14,24H,9-12,15H2
Standard InChI Key: MSCYJFQRYSADGM-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
6.2700 -4.8171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2687 -5.6411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9870 -6.0544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9851 -4.4039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4982 -5.2332 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1426 -4.4862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3398 -4.3028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1404 -5.9733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3366 -6.1563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6958 -5.6387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6948 -4.8130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5534 -6.0540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8381 -5.6410 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.1229 -6.0539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4178 -4.9227 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2438 -4.9227 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4094 -5.6401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6947 -6.0523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6942 -6.8790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4144 -7.2920 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1262 -6.8773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9814 -7.2945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2652 -6.8807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5510 -7.2939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5516 -8.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2724 -8.5326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9837 -8.1170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1626 -8.5354 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
2 12 1 0
6 7 1 0
12 13 1 0
5 8 1 0
13 14 1 0
9 10 1 0
13 15 2 0
10 11 1 0
13 16 2 0
11 7 1 0
14 17 2 0
8 9 1 0
17 18 1 0
2 3 1 0
18 19 2 0
19 20 1 0
3 10 2 0
20 21 2 0
21 14 1 0
22 23 2 0
1 2 2 0
23 24 1 0
11 4 2 0
24 25 2 0
4 1 1 0
25 26 1 0
26 27 2 0
27 22 1 0
19 22 1 0
25 28 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 396.49 | Molecular Weight (Monoisotopic): 396.1308 | AlogP: 3.55 | #Rotatable Bonds: 4 |
Polar Surface Area: 59.06 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.86 | CX LogP: 3.54 | CX LogD: 1.14 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.73 | Np Likeness Score: -1.32 |
References
1. Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM.. (2009) The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor., 19 (22): [PMID:19804969] [10.1016/j.bmcl.2009.09.027] |